Our Retired Founding Partners

Founding Partners


We Have Recently Moved Our Greece Location

We've recently moved our Greece location to 103 Canal Landing Blvd., Suite 12, Rochester, NY 14626. Our phone and fax numbers remain the same.

Dr. Kothari Receives Edward Mott Moore Award

This award is awarded by the Monroe County Medical Society and is presented to a physician and a layperson whose lives reflect the qualities exemplified by Dr. Edward Mott Moore as a physician, teacher, investigator, leader and contributor to the community. Dr. Moore, a prominent New York State physician, became a professor of surgery in 1842, at 28 years of age. He was soon recognized as an outstanding teacher of surgery and between 1842 and 1883, was appointed professor of surgery successively at four different medical schools. Dr. Moore was surgeon-in-chief at St. Mary's Hospital from its opening in 1857 until his death in 1902 at the age of 88. Congratulations Dr. Kothari.


RGA recognized by ASGE as being in the top 100 Endoscopy Unit Recognition Program

ASGE Congratulates EURP Honorees in Your Area Over 100 units strong are part of the ASGE Endoscopy Unit Recognition Program (EURP) in just the northeast alone. As participants in the EURP, these units are part of a growing national network that is recognized for their dedication to high-quality Gastroenterology care.

RGA is committed to the following important quality improvement principles:

  • •A strong focus on patients;
  • •Continuous quality improvement;
  • •Involvement of the entire organization in the pursuit of quality;
  • •Use of data and team knowledge to improve decision-making.

Dr. Kothari Retires December 31, 2015

Dr. Kothari's first patient was in 1979 and his last patient was December 2015. Dr. Kothari will be missed.

Dr. Kothari's last patient

Dr. Kothari Retirement Get Together

Dr. Kothari Retirement Party Dr. Kothari Retirement

Dr. Kothari Retirement Dr. Kothari Retirement


March Is Colon Cancer Awarness Month

A good resource poster. Why take chances
Please view an industry standard fact sheet. Fact Sheet
The ACG Guidlines is another great resource. ACG Guidline

We Have Received Recognition from the American Society for Gastrointestinal Endoscopy

We are pleased to announce that on 12/30/2014 Rochester Endoscopy Associates was recognized by the American Society for Gastrointestinal Endoscopy for promoting quality in endoscopy. We looking forward to serving your needs. An ounce of prevention does go a long way.

We Have Launched Our New Patient Portal

We are excited to announce the addition of a patient portal to our Practice called FollowMyHealth. Please click on the link to join the portal. You will be able to send secure messages to your physician or to the office, view your chart data, schedule an appointment and view your demographic information. Additional options will be available at a later date.


Wall Street Journal Article- More Screenings Put Dent in Colon Cancer

Great article from the Wall Street Journal in regards to why awareness and Colon Cancer screening is important to survival.


Introducing Health e-Pay

Rochester Gastro Enterology Associates is striving to make the patient experience as simple as possible. To that end we are proud to introduce our new health e-pay system. More information can be found at the link health e-pay program

Fecal Transplant Cost Effective for Recurrent C Difficile

Jim Kling October 25, 2013 SAN DIEGO

A new analysis of the cost effectiveness of various strategies to combat recurring Clostridium difficile infections (CDIs) shows that fecal microbial transplantation delivered by colonoscopy is the best approach.

"Fecal transplant has emerged as a new and effective therapy for CDI, but we know there are costs associated with it," Gauree Gupta Konijeti, MD, a fellow at Massachusetts General Hospital in Boston, told Medscape Medical News. "We wanted to see whether it makes sense on a cost-effectiveness scale." Dr. Konijeti presented the results here at the American College of Gastroenterology 2013 Annual Scientific Meeting. There are now several options available to treat the condition, but they have not been evaluated for cost effectiveness when both the initial treatment cost and the health benefits of preventing recurrence have been taken into account. Dr. Konijeti and her team used a decision-analytic model to compare the cost effectiveness of 4 treatment strategies for a first episode of CDI: fecal transplantation, metronidazole, vancomycin, and fidaxomicin. The team tested up to 2 recurrences after the initial episode.

Fecal transplantation delivered by colonoscopy had an incremental cost-effectiveness ratio of $46,419, compared with vancomycin. It also easily outperformed fidaxomicin and metronidazole because of the higher costs and lower efficacy of these drugs. Fecal transplantation remained the most cost-effective approach, with cure rates higher than 96.4%, a CDI recurrence rate below 6.9%, and a cost of less than $1223. The researchers also constructed a model of fecal transplantation that was delivered by enema or nasoduodenal infusion, but found that colonoscopy was more cost effective because it's efficacy is better than the other 2 delivery systems.

Transplantation by Enema or Nasoduodenal Infusion Dr. Konijeti expressed optimism that fecal transplantation delivered by enema or nasoduodenal infusion could, with improvements, match the efficacy of colonoscopy-delivered transplants. "We typically use lower fecal microbiota doses for nasoduodenal and enema delivery, which might be one of the reasons they don't have similar efficacy," she said. If comparable efficacy could be achieved, these delivery systems would be preferable because they cost less than colonoscopy. In clinical settings where colonoscopy was not available, the researchers found that vancomycin was the most cost-effective option.

The cost of fidaxomicin, at $462,706 per quality-adjusted life year, is prohibitive compared with the older drug. "It's a timely study because recurrent C difficile is truly recurrent; a lot of patients have multiple episodes over a period of time," session moderator Jonathan Leighton, MD, from Mayo Clinic Arizona in Scottsdale, told Medscape Medical News. "I think the primary reason that fecal transplant was shown to be the most cost-effective strategy is that, at least in studies to date, fecal transplant has the highest cure rates. You don't have multiple recurrences if you treat them that way." Dr. Konijeti and Dr. Leighton have disclosed no relevant financial relationships. American College of Gastroenterology 2013 Annual Scientific Meeting and Postgraduate Course: Abstract 9.

Presented October 14, 2013. Medscape Medical News © 2013 WebMD, LLC Send comments and news tips to Cite this article: Fecal Transplant Cost Effective for Recurrent C difficile. Medscape. Oct 25, 2013.

Welcome Dr. Chodos

Dr. Chodos

The staff and practicioners at Rochester Gastroenterology Associates, LLP, are excited to welcome Dr. Ari Chodos as our newest provider of Gastroenterology services to our practice.

Dr. Chodos has relocated to Rochester, from New Jersey, where he completed his training in Gastroenterology and advanced therapeutic endoscopy at the UNDMJ-New Jersey Medical School. He completed his medical school training at Trinity College in Dublin, Ireland. Dr. Chodos is an expert in all basic endoscopic techniques including EGD, ERCP, and colonoscopy and will be joining Dr. Devgun in providing endoscopic ultrasound (EUS) examinations.


Endoscopy Center Dedication

The Providers and Staff at Rochester Gastroenterology Associates and Rochester Endoscopy Associates are proud to share this exciting news. The new Endoscopy center at Unity Hospital was dedicated on November 8, 2012 and named after the practice's senior partner, Dr. Tarun Kothari as well as his spouse Dr. Kamal Kothari. This is in recognition of their generous donation to the Endoscopy Unit at Unity Hospital, Dr. Tarun Kothari's has provided stewardship as Chief of Gastroenterology and has served Unity Hospital for over 30 yrs. He has also been a longstanding member of the Unity Hospital board and foundation and was recognized for his leadership and philanthropy. In addition we also thank past partners of RGA Dr's Ravi Sharma and Krishan Thanik as well as their spouses for their generous support.

The Unity Endoscopy center has also received financial support from the Rochester Gastroenterology partners, Drs. Penmetsa and Devgun, and from many of the Physicians practicing at the Endoscopy unit. This is in keeping with great tradition of giving in Rochester.

Endoscopy Center Dedication Endoscopy Center